Covered recipient · General Payments record
LEXINE HOWARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Anesthetist, Certified Registered
General Payments · PY2022–2024
$511.48
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $331.39 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.25 | 9 |
| Janssen Biotech, Inc. | $77.71 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.09 | 2 |
| Ardelyx, Inc. | $36.34 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.36 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361419 | CMS |
| ABBVIE INC. | $17.68 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361421 | CMS |
| ABBVIE INC. | $22.54 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361423 | CMS |
| ABBVIE INC. | $16.35 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361425 | CMS |
| ABBVIE INC. | $17.89 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361427 | CMS |
| ABBVIE INC. | $15.40 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361429 | CMS |
| ABBVIE INC. | $20.92 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361431 | CMS |
| ABBVIE INC. | $16.14 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361433 | CMS |
| ABBVIE INC. | $26.97 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107361435 | CMS |
| Ardelyx, Inc. | $13.13 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146731042 | CMS |
| Ardelyx, Inc. | $23.21 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146731044 | CMS |
| Janssen Biotech, Inc. | $18.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078468642 | CMS |
| Janssen Biotech, Inc. | $19.87 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078467512 | CMS |
| Janssen Biotech, Inc. | $18.44 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078467529 | CMS |
| Janssen Biotech, Inc. | $21.01 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078464594 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.18 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137765811 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.91 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137765813 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.